Phase I/II study everolimus in combination with paclitaxel-carboplatin in patients with advanced adenocarcinoma of the stomach

被引：0
|
作者：
Loong, H. H. [1 ]
Mo, F. [1 ]
Li, L. [2 ]
Lee, C. [3 ]
Lam, K-C. [2 ]
Koh, J. [1 ]
Chiu, P. [4 ]
Teoh, A. [4 ]
Chan, A. T. C. [1 ]
Ng, E. [4 ]
Yeo, W. [1 ]
机构：
[1] Chinese Univ Hong Kong, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China
[2] Prince Wales Hosp, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China
[3] United Christian Hosp, Dept Oncol, Hong Kong, Hong Kong, Peoples R China
[4] Chinese Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
402P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase I-II study of paclitaxel-carboplatin (PC) weekly combination chemotherapy in esophageal carcinoma.
    D'Addario, G
    Morant, R
    Cerny, T
    ANNALS OF ONCOLOGY, 2000, 11 : 91 - 91
  • [2] Phase I/II study of DHA–paclitaxel in combination with carboplatin in patients with advanced malignant solid tumours
    M Harries
    A O'Donnell
    M Scurr
    S Reade
    C Cole
    I Judson
    A Greystoke
    C Twelves
    S Kaye
    British Journal of Cancer, 2004, 91 : 1651 - 1655
  • [3] A Phase II Study Evaluating the Combination of Everolimus with Carboplatin/Paclitaxel as 1st Line Treatment in Patients with Advanced LCNEC
    Grohe, Christian
    Engel-Riedel, Walburga
    Kropf-Sanchen, Cornelia
    Joachim, Von Pawel
    Guetz, Sylvia
    Kollmeier, Jens
    Eberhardt, Wilfried
    Christopoulos, Petros
    Nimmrich, Inko
    Sieder, Christian
    Baum, Volker
    Serke, Monika
    Thomas, Michael
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S697 - S697
  • [4] Phase I/II study of DHA-paclitaxel in combination with carboplatin in patients with advanced malignant solid tumours
    Harries, M
    O'Donnell, A
    Scurr, M
    Reade, S
    Cole, C
    Judson, I
    Greystoke, A
    Twelves, C
    Kaye, S
    BRITISH JOURNAL OF CANCER, 2004, 91 (09) : 1651 - 1655
  • [5] A phase II study of combination paclitaxel and carboplatin in advanced nasopharyngeal carcinoma
    Yeo, W
    Leung, TWT
    Chan, ATC
    Chiu, SKW
    Yu, P
    Mok, TSK
    Johnson, PJ
    EUROPEAN JOURNAL OF CANCER, 1998, 34 (13) : 2027 - 2031
  • [6] Weekly paclitaxel in combination with carboplatin: A phase I study in advanced malignancies
    Belani, CP
    Ramanathan, RK
    SEMINARS IN ONCOLOGY, 1999, 26 (06) : 63 - 63
  • [7] Phase II study of paclitaxel-carboplatin (PC) weekly combination chemotherapy in advanced non small cell lung cancer (NSCLC).
    Cerny, T
    D'Addario, G
    Morant, R
    ANNALS OF ONCOLOGY, 2000, 11 : 118 - 118
  • [8] Everolimus in combination with paclitaxel and carboplatin in patients with advanced melanoma: A phase II trial of the Sarah Cannon Research Institute (SCRI)
    Hauke, Ralph J.
    Infante, Jeffrey R.
    Shih, Kent C.
    Rubin, Mark S.
    Arrowsmith, Edward
    Whorf, Robert C.
    Hainsworth, John D.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [9] A phase I study to assess afatinib in combination with carboplatin or with carboplatin plus paclitaxel in patients with advanced solid tumors
    Mary E. R. O’Brien
    Debashis Sarker
    Jaishree Bhosle
    Kiruthikah Thillai
    Timothy A. Yap
    Martina Uttenreuther-Fischer
    Karine Pemberton
    Xidong Jin
    Sabrina Wiebe
    Johann de Bono
    James Spicer
    Cancer Chemotherapy and Pharmacology, 2018, 82 : 757 - 766
  • [10] A phase I study to assess afatinib in combination with carboplatin or with carboplatin plus paclitaxel in patients with advanced solid tumors
    O'Brien, Mary E. R.
    Sarker, Debashis
    Bhosle, Jaishree
    Thillai, Kiruthikah
    Yap, Timothy A.
    Uttenreuther-Fischer, Martina
    Pemberton, Karine
    Jin, Xidong
    Wiebe, Sabrina
    de Bono, Johann
    Spicer, James
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 82 (05) : 757 - 766
12345